|
Jan 12
|
Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine
|
|
Jan 12
|
Dow Jones Falls On Cool Inflation Data; Tesla Stock Slides Despite Cathie Wood Buys
|
|
Jan 12
|
Should You Invest in Novo Nordisk (NVO) Based on Bullish Wall Street Views?
|
|
Jan 12
|
No Evidence New Obesity Drugs Cause Suicidal Thoughts, FDA Says
|
|
Jan 12
|
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
|
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
|
Jan 9
|
Dow Jones Futures Fall: Magnificent Seven Stocks Rally; Nvidia Breaks Out Past Buy Point
|
|
Jan 8
|
Wall Street Raises The Bar For These Four Stocks In 2024
|
|
Jan 8
|
Dow Jones Leader Amgen Extends Gains Past Buy Point; Ozempic Maker Novo Nordisk Breaks Out
|
|
Jan 8
|
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
|
|
Jan 8
|
Eli Lilly CEO: 'I think a bet on Lilly is to bet we can keep on inventing new things'
|
|
Jan 8
|
Wegovy and Ozempic Maker Novo Nordisk Shares Data From Phase 3 Diabetes Study Of Semaglutide/Insulin Containing Candidate
|
|
Jan 8
|
Dow Jones Falls As Boeing Dives On Groundings; Nvidia Stock Hits Record High
|
|
Jan 8
|
Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates
|
|
Jan 8
|
Could Novo Nordisk Stock Help You Retire a Millionaire?
|
|
Jan 8
|
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
|
|
Jan 6
|
Nvidia, Spotify Lead Five Stocks Near Buy Points
|
|
Jan 5
|
Novo Nordisk, IBD Stock Of The Day, Flashes Buy Signal Amid The Weight-Loss Craze
|
|
Jan 5
|
How weight loss drug costs could impact providers, taxpayers
|
|
Jan 5
|
People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds
|